JP2025515191A5 - - Google Patents

Info

Publication number
JP2025515191A5
JP2025515191A5 JP2024565319A JP2024565319A JP2025515191A5 JP 2025515191 A5 JP2025515191 A5 JP 2025515191A5 JP 2024565319 A JP2024565319 A JP 2024565319A JP 2024565319 A JP2024565319 A JP 2024565319A JP 2025515191 A5 JP2025515191 A5 JP 2025515191A5
Authority
JP
Japan
Prior art keywords
disease
syndrome
fusion protein
autoimmune
protein according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024565319A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025515191A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2023/054722 external-priority patent/WO2023214388A1/en
Publication of JP2025515191A publication Critical patent/JP2025515191A/ja
Publication of JP2025515191A5 publication Critical patent/JP2025515191A5/ja
Pending legal-status Critical Current

Links

JP2024565319A 2022-05-06 2023-05-05 新規cd200融合タンパク質 Pending JP2025515191A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2206673.2 2022-05-06
GB202206673 2022-05-06
PCT/IB2023/054722 WO2023214388A1 (en) 2022-05-06 2023-05-05 Novel cd200 fusion proteins

Publications (2)

Publication Number Publication Date
JP2025515191A JP2025515191A (ja) 2025-05-13
JP2025515191A5 true JP2025515191A5 (cg-RX-API-DMAC10.html) 2026-05-14

Family

ID=86609511

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024565319A Pending JP2025515191A (ja) 2022-05-06 2023-05-05 新規cd200融合タンパク質

Country Status (10)

Country Link
US (1) US20260116946A1 (cg-RX-API-DMAC10.html)
EP (1) EP4519298A1 (cg-RX-API-DMAC10.html)
JP (1) JP2025515191A (cg-RX-API-DMAC10.html)
KR (1) KR20250025619A (cg-RX-API-DMAC10.html)
CN (1) CN119522234A (cg-RX-API-DMAC10.html)
AU (1) AU2023265174A1 (cg-RX-API-DMAC10.html)
CA (1) CA3251039A1 (cg-RX-API-DMAC10.html)
IL (1) IL316697A (cg-RX-API-DMAC10.html)
MX (1) MX2024013669A (cg-RX-API-DMAC10.html)
WO (1) WO2023214388A1 (cg-RX-API-DMAC10.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2626300A (en) * 2022-12-08 2024-07-24 Ducentis Biotherapeutics Ltd Mutated CD200 proteins and methods of use therof
WO2025106841A1 (en) * 2023-11-15 2025-05-22 The University Of Chicago Methods and compositions for inducing antigen specific tolerance

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637481A (en) 1993-02-01 1997-06-10 Bristol-Myers Squibb Company Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispecific fusion proteins in a mammalian cell
DE69226871T3 (de) 1991-06-27 2009-09-24 Bristol-Myers Squibb Co. CTL4A-Rezeptor, ihn enthaltenden Fusionsproteine und deren Verwendung
EP1171154A2 (en) 1999-04-13 2002-01-16 Schering Corporation Uses of mammalian ox2 protein and related reagents
US8367805B2 (en) * 2004-11-12 2013-02-05 Xencor, Inc. Fc variants with altered binding to FcRn
WO2008089022A2 (en) 2007-01-11 2008-07-24 Boehringer Ingelheim International Gmbh Cd200 and its receptor, cd200r, modulate bone mass via the differentiation of osteoclasts
GB201608197D0 (en) * 2016-05-10 2016-06-22 Ducentis Biotherapeutics Ltd Novel proteins

Similar Documents

Publication Publication Date Title
TWI291468B (en) Crystal of etanercept and its preparing method and use
US11203628B2 (en) CD200 mutants and its uses
JP2015526064A5 (cg-RX-API-DMAC10.html)
JP2020528894A5 (cg-RX-API-DMAC10.html)
EP3464347B1 (en) Cysteine-optimized stradomers
JP2024542096A5 (cg-RX-API-DMAC10.html)
US20260116946A1 (en) Novel cd200 fusion proteins
US20250026805A1 (en) Novel proteins
EP4630445A2 (en) Taci-fc fusion proteins for multifunctional inhibition of baff, april, and neonatal fc receptor
JP2025516364A5 (cg-RX-API-DMAC10.html)
WO2025087363A1 (zh) 用TACI-Fc融合蛋白治疗自身免疫性脑炎的方法
JP2024546654A5 (cg-RX-API-DMAC10.html)
NZ747665B2 (en) Cd200 mutant and its uses
JP2022513490A5 (cg-RX-API-DMAC10.html)
RU2023135361A (ru) Белки, которые связываются с cd80 и/или cd86 и ox40l
JP2025516364A (ja) 新規cd200融合タンパク質
CN121152636A (zh) 用TACI-Fc融合蛋白治疗ANCA相关性血管炎的方法
JP2024524880A5 (cg-RX-API-DMAC10.html)
KR20260007620A (ko) Cd200 융합 단백질
BR122025011067A2 (pt) Composição que compreende um anticorpo anti-il-5 e composição farmacêutica que compreende a dita composição
BR122025011033A2 (pt) Composição que compreende um anticorpo anti-il-5, uso terapêutico da mesma, bem como composição farmacêutica que compreende a dita composição